Chronic fatigue syndrome a possible long-term effect of Covid-19, experts say


Chronic fatigue syndrome a possible long-term effect of Covid-19, experts say – CNN https://edition.cnn.com/2020/08/07/health/chronic-fatigue-syndrome-covid-19-survivors-wellness/index.html?utm_medium=social&utm_source=fbCNN&utm_term=link&utm_content=2020-08-17T02%3A31%3A06

What It’s Really Like To Live With High-Functioning Depression


What It’s Really Like To Live With High-Functioning Depression | HuffPost https://m.huffpost.com/us/entry/us_5c140a50e4b05d7e5d81ea9d?ncid=fcbklnkushpmg00000063&utm_source=main_fb&utm_campaign=hp_fb_pages&utm_medium=facebook

How To Burn Fat While Running


How To Burn Fat While Running https://www.runtastic.com/blog/en/how-to-burn-fat-while-running/?utm_content=in.burn-fat-while-running&utm_source=runtastic&utm_medium=facebook.en&utm_campaign=cardio&utm_term=paid

Preserving The Dead Bodies: The Chemistry Behind Mummification.


Preserving The Dead Bodies: The Chemistry Behind Mummification. https://www.secretsofuniverse.in/chemistry-behind-mummification/

Attention is the Key to Open the Doors of the Existence


Attention is the Key to Open the Doors of the Existence https://isha.sadhguru.org/in/en/wisdom/video/daily-wisdom-attention-key-to-existence

CanSino’s COVID-19 vaccine candidate gets first patent; Phase III trials begin in Russia


CanSino’s COVID-19 vaccine candidate gets first patent; Phase III trials begin in Russia – Republic World https://m.republicworld.com/world-news/rest-of-the-world-news/cansinos-covid-19-vaccine-candidate-begins-phase-iii-trials-in-russia.html

Cyborg: Human organs could soon merge with computers to monitor health


Cyborg: Human organs could soon merge with computers to monitor health | Daily Mail Online https://www.dailymail.co.uk/sciencetech/article-8635211/Cyborg-Human-organs-soon-merge-computers-monitor-health.html?ito=social-facebook

Remdesivir Clinical Trials


Remdesivir Clinical Trials https://www.gilead.com/purpose/advancing-global-health/covid-19/remdesivir-clinical-trials

Remdesivir for the Treatment of Covid-19.


Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2007764